Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-γ treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume -, Issue -, Pages annrheumdis-2020-217798
Publisher
BMJ
Online
2020-06-20
DOI
10.1136/annrheumdis-2020-217798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis
- (2019) Yang Luo et al. EBioMedicine
- Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017
- (2019) Saeid Safiri et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders
- (2019) Keith J. Johnson et al. CLINICAL RHEUMATOLOGY
- Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis
- (2018) Yi Yang et al. Journal of Translational Medicine
- Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
- (2018) Sujuan Yang et al. Frontiers in Immunology
- Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39–CD73–Adenosine and IDO Signals
- (2017) Feng Huang et al. Frontiers in Immunology
- Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry
- (2016) Pongthorn Narongroeknawin et al. International Journal of Rheumatic Diseases
- Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease
- (2015) Martino Introna et al. Current Opinion in Organ Transplantation
- Mesenchymal stem cells and adaptive immune responses
- (2015) Wei Cao et al. IMMUNOLOGY LETTERS
- Culture medium from TNF-α–stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms
- (2015) Wenru Su et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Stem cell therapy for inflammatory bowel disease
- (2015) Kanna Nagaishi et al. JOURNAL OF GASTROENTEROLOGY
- Human Umbilical Cord Blood Mesenchymal Stem Cell-Derived PGE2and TGF-β1 Alleviate Atopic Dermatitis by Reducing Mast Cell Degranulation
- (2015) Hyung-Sik Kim et al. STEM CELLS
- Novel therapeutic targets in rheumatoid arthritis
- (2015) Marije I. Koenders et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mesenchymal Stem Cells Differentially Modulate Effector CD8+ T Cell Subsets and Exacerbate Experimental Autoimmune Encephalomyelitis
- (2014) Justin D. Glenn et al. STEM CELLS
- The interaction between mesenchymal stem cells and steroids during inflammation
- (2014) X Chen et al. Cell Death & Disease
- Immunobiology of mesenchymal stem cells
- (2013) S Ma et al. CELL DEATH AND DIFFERENTIATION
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy
- (2013) Liming Wang et al. STEM CELLS AND DEVELOPMENT
- Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance
- (2012) Ning Kong et al. ARTHRITIS AND RHEUMATISM
- Mechanisms of mesenchymal stromal cell immunomodulation
- (2012) Karen English IMMUNOLOGY AND CELL BIOLOGY
- The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study
- (2011) N. B. Klarenbeek et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?
- (2010) Lisette Bevaart et al. ARTHRITIS AND RHEUMATISM
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
- (2010) Lingyun Sun et al. ARTHRITIS AND RHEUMATISM
- Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
- (2010) Peter C Taylor CURRENT OPINION IN PHARMACOLOGY
- Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner
- (2009) Moutih Rafei et al. JOURNAL OF IMMUNOLOGY
- Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
- (2009) K. Nistala et al. RHEUMATOLOGY
- Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis
- (2009) Gabriela Constantin et al. STEM CELLS
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
- The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function
- (2008) Rajesh Ramasamy et al. CELLULAR IMMUNOLOGY
- Regulatory T cells (Treg) in rheumatoid arthritis
- (2008) Marie-Christophe Boissier et al. JOINT BONE SPINE
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now